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Surgical oncology is a field of Medicine 
that presented a rapid evolution over the 
past decades. The increasing incidence of 
malignancies throughout the globe and 
their detrimental effects led to an increas-
ing interest in discovering new curative 
techniques, that could affect and prolong 
the patients’ life. Surgery has been the 
cornerstone and its course underwent 
dramatic changes over the years. Since the 
beginning of the twentieth century, the aim 
of the surgeons was to offer the maximal 
tolerable treatment, as their efforts were 
focused on delivering as extensive surgical 
treatments as the patients could tolerate, in 
order to achieve an acceptable disease con-
trol. This approach resulted in unnecessary 
mutilating interventions that had tremen-
dous effects on the patients’ quality of life. 
The most characteristic example of this era 
was the radical mastectomy performed for 
breast cancer, that was a devastating expe-
rience for breast cancer survivors. At the 
end of the 1960s, when it was made evi-
dent that the prognosis was mainly linked 
to the presence of distant metastases and 
not to the extent of the local treatment, 
the opposite trend was developed. The 
main objective was to identify the minimal 
effective treatment, targeting at the pres-
ervation of the anatomy and functional-
ity of the affected organ, that would also 
improve the patients’ quality of life. At the 
same time emerged the necessity for a new 
set of investigations for a better control of 
occult metastases.
The advances in the field of medical 
oncology have led to an improved control 
of the systemic disease. Adjuvant chemo-
therapy and endocrine therapy became an 
important component of the treatment, 
aiming at the improvement of overall sur-
vival in breast, colon, and lung cancer. More 
recently the new biomolecular targeted 
treatments pointed at increasing the thera-
peutic efficiency, sparing the oncological 
patient the debilitating side effects of the 
traditional chemotherapy. Her 2 inhibitors 
for breast cancer, imatinib for GIST, BRAF 
inhibitors for melanoma, EGFR tyrosine 
kinase inhibitors for non-small cell lung 
cancer are just some of the examples of 
targeted therapies that recently became 
standard treatments.
The value of radiotherapy is well known, 
as it is often essential for obtaining local 
control (Stea et al., 2011). The progression 
of technology changed the delivery of radia-
tion from two-dimensional radiotherapy to 
three-dimensional conformal radiotherapy 
and recently to intensity modulated radia-
tion therapy. Image guided radiotherapy, 
stereotactic body radiotherapy, and stereo-
tactic radiosurgery are some other modern 
methods that emerged over the past decade 
(Orvieto et al., 2011). Brachytherapy and 
intraoperative radiotherapy are new prom-
ising modalities that allow the delivery of 
radiotherapy for either short periods or 
during the surgical intervention, thus mini-
mizing the extend of radiation fields and 
concentrating the major part of therapeutic 
intervention in only one session, aiming at 
improving the patients quality of life.
Neoadjuvant treatments are currently 
being used for downstaging. Chemotherapy 
and radiotherapy, as well as hormone ther-
apy for hormone dependent malignancies, 
in the pre-operative setting are shown to 
decrease the extent of the solid tumors, ren-
dering them operable, without excising the 
affected organ.
Similarly, the progress of Nuclear 
Medicine has improved the results of sur-
gical oncology in the diagnostic setting, 
with the technique of the sentinel lymph 
node, used in breast cancer, in melanoma, in 
gynecological, and head and neck tumors. 
Positive emission tomography is becom-
ing an essential tool for whole body stag-
ing of cancer. In the therapeutic setting, 
radioactive iodine ablation is used for thy-
roid malignancies and recently radioim-
munotherapy with yttrium seems to have 
promising results not only for hematologic 
malignancies, but also for solid tumors 
(Pohlman et al., 2006).
The latest generations of surgeons have 
witnessed the transition from open surgery 
to laparoscopic or video-assisted surgery 
and soon after to robotic surgery. This is all 
attributed to the revolution of technology, 
that allows the surgeon to access the cavi-
ties of the human body and operate inside 
them using sophisticated instruments, that 
make extremely precise and delicate move-
ments under the surgeon’s commands. 
Laparoscopic surgery is widely used in the 
last 20 years for malignancies of all intra 
and extraperitoneal organs, while video-
assisted surgery is a mainstay in thoracic 
surgery. Robotic surgery is already estab-
lished in many fields, especially in urology, 
with a large number of radical prostatecto-
mies, as well as nephrectomies, performed 
robotically. The main benefit of all these 
minimally invasive techniques is the lim-
ited insult, not only of the target organ, but 
also of the adjacent structures, resulting in 
a faster recovery and a shorter hospitaliza-
tion, maintaining in most cases the normal 
physiological functions.
It is clear that the implementation of 
the above mentioned approach can only 
be performed in cases of early, small sized, 
cancers confined to the target organ. Early 
detection of cancer has contributed signifi-
cantly to the advance of surgical oncology, 
as it was shown to affect both the treatment 
strategy toward minimal intervention and 
organ saving techniques, and the prognosis. 
The population screening programs are an 
essential part of every national health sys-
tem and their beneficial effect is well known. 
The mammography for breast cancer, the 
colonoscopy for colon cancer, the pap-test 
for cervical cancer, and the spiral computed 
tomography for lung cancer are included in 
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to act in his/her patient’s interest even if it 
may conflict his/her own and his main task 
is not just to prolong the patient’s life, but to 
improve its quality. He/she should approach 
the patients not as cancer cases, aiming at 
treating the cancer, but he/she should take 
into to account the human parameters of 
each patient, aiming at curing the cancer 
patient of his/her disease, and its psycho-
logical consequences.
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oncologist should not remain isolated in the 
operating theater, but he/she should learn to 
interact with other specialists and develop 
non-technical skills, like communication, 
leadership, organization, and situational 
awareness (Aggarwal and Grantcharov 
2011).
The role of training and continuous edu-
cation in surgical oncology is fundamental 
in the era of information technology and 
super-specialization. The surgical oncolo-
gist should be exposed to a large number 
of operations and should become familiar 
with advanced technology instruments and 
techniques. At the same time he/she should 
not only act as a technician, but as a real sci-
entist, being able to understand the results 
of basic and clinical research beyond the 
surgical domain, and integrate them into 
his/her everyday practice. Information tech-
nology is a useful tool for disseminating on 
line knowledge in every part of the world 
and thanks to it, continuous education is 
made feasible.
Probably the most important challenge 
in the surgical oncology of the twenty-first 
century remains the philosophic value of 
humanism. In the era of rapid technologi-
cal advances, of functional genomics and 
proteomics applied to cancer, of increas-
ing health market, the doctor-patient rela-
tionship should be based on trust, respect 
toward the doctor and on selflessness, avail-
ability, honesty, and compassion toward the 
patient. The surgical oncologist is required 
the screening guidelines of all health organi-
zations and had a noteworthy impact on 
these malignancies.
Despite the enthusiasm of all the pro-
gress that has been achieved in the field of 
technology, which has altered many of the 
traditional concepts in surgical oncology 
in the last 50 years, the big challenge that 
the modern surgical oncologist is facing is 
the integration of all the new knowledge 
in a system that will be patient centered. 
Multidisciplinary approach for cancer cases 
and decision making are basic elements for 
the management of the oncologic patient. 
The surgical oncologist should be part of a 
multidisciplinary team that discusses every 
single cancer case and aims at selecting the 
best available combination of diagnostic 
and therapeutic procedures, taking into 
consideration the different characteristics 
of each patient. All cancer centers world-
wide have already implemented this team 
approach in oncology, as the available 
modalities for diagnosis and treatment are 
continuously increasing and each special-
ist is becoming an expert in a certain field. 
The goal of the multidisciplinary meeting 
is to decide the most suitable approach, tai-
lored to the needs of every patient, using the 
most appropriate procedures of every rel-
evant field of medicine. Inter-professional 
communication, patient centered medical 
approach, and integrated health delivery are 
new concepts that should characterize the 
surgical oncology of the future. The surgical 
